The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
An Exploration Of The Interface Between Indigenous Knowledge And Anti-cancer Potential Of Traditionally Used Plants.
Funder
National Health and Medical Research Council
Funding Amount
$308,954.00
Summary
This research is directed towards embedding a model that enables the integration of Indigenous and Western-scientific knowledge of medicinal plants with anti-cancer properties or desirable bioactivities which may be associated with relieving the side effects of cancer treatment. Improved relationship and capacity building will be achieved through social engagement activties between Indigenous and Western researchers by teaching scientific related skills and knowledge related to practices conduct ....This research is directed towards embedding a model that enables the integration of Indigenous and Western-scientific knowledge of medicinal plants with anti-cancer properties or desirable bioactivities which may be associated with relieving the side effects of cancer treatment. Improved relationship and capacity building will be achieved through social engagement activties between Indigenous and Western researchers by teaching scientific related skills and knowledge related to practices conducted on traditional homelands.Read moreRead less
The Role Survivin And XIAP (X-linked Inhibitor Of Apoptosis Protein) As Biomarkers And Therapeutic Targets In Paediatric Acute Myeloid Leukaemia.
Funder
National Health and Medical Research Council
Funding Amount
$294,218.00
Summary
I am a Paediatric Haematologist/Oncologist focussing on new treatments for childhood acute myeloid leukaemia. This study is examining the effects of conventional and novel therapies on two proteins that prevent cell death in acute myeloid leukaemia. The study will also develop clinical trials of new drugs targeting these proteins.
The Potential Of Blocking Translation Initiation For Cancer Therapy
Funder
National Health and Medical Research Council
Funding Amount
$347,792.00
Summary
Treatment of many cancers remains unsatisfactory and new drugs for treating them are urgently required. By determining how a new class of anti-cancer drugs kills cancer cells and whether they might also affect normal cells, we can determine how they can be optimally given to patients suffering from cancer.
Cellular Response To Modulation Of Iron Levels: Studies Examining ASK1, Thioredoxin And Ribonucleotide Reductase
Funder
National Health and Medical Research Council
Funding Amount
$33,055.00
Summary
Iron is crucial for many essential biological processes. Recently, I demonstrated that iron-depletion can affects signalling pathways that play important roles in cellular growth and death. This study is designed to investigate the cellular and molecular effects of iron depletion which currently remains unclear. My proposed research is crucial for understanding: (1) the effects of iron-deficiency and (2) for understanding the effects of iron chelators that are used for treating various diseases.
Exploring The Structure Activity Relationships Of Novel Trypsin Inhibitor SFTI-1 With Implications As Cancer Therapeutic
Funder
National Health and Medical Research Council
Funding Amount
$360,312.00
Summary
A novel peptide isolated from sunflower seeds has recently been shown to interact with an enzyme implicated in the growth of cancers and in particular prostate cancer. The proposed research involves developing this peptide as a therapeutic by performing a thorough analysis of the important features involved in its exciting anti-cancer activity.
Identiification Of Novel Biomarkers And Therapeutic Targets For The Treatment Of Pancreatic Cancer
Funder
National Health and Medical Research Council
Funding Amount
$362,463.00
Summary
Pancreatic cancer is a devastating disease with an appalling prognosis - only 6% of patient survive 5 years after diagnosis. The aim of this research is to use new technologies to find out how pancreatic cells become malignant and why the cancerous cells are so drug resistant. The goal is to ideantify cell markers to guide drug treatment design and new targets for antibody therapy. By combining emerging technologies we hope to achieve break-through outcomes in the treatment of pancreatic cancer.
Structural And Functional Studies Of The Human IL-3 Receptor
Funder
National Health and Medical Research Council
Funding Amount
$307,946.00
Summary
This proposal will study a protein hormone that is implicated in blood cell cancers and inflammatory diseases and for which current treatments are inadequate. We will determine how the hormone receptor becomes activated, identify and characterise new agents that block this activation. This information will help in the development of new and highly specific drugs for use in certain cancers in inflammatory diseases.
Identifying And Preventing Inflammation-induced Brain Injury In Preterm Infants
Funder
National Health and Medical Research Council
Funding Amount
$338,652.00
Summary
Exposure to infection/inflammation around the time of birth is one of the most common factors associated with long-term disability. There is no effective treatment. My studies will use world-class techniques for measuring brain structure and function to improve our understanding of how infection/inflammation impacts on development of the preterm brain and determine whether blocking key inflammatory pathways in the brain will help restore normal brain growth and development in preterm infants.
Eliminating HCV: Statistical Modelling And Health Economic Evaluation In The New DAA Era
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
While new generation hepatitis C virus (HCV) treatments are highly efficacious, their high cost means multi-pronged approaches will be needed to reach elimination targets. This project will use statistical and mathematical modelling to inform real world health economic evaluations determine the most cost-effective response. This will inform health policy in Australia and globally.